Authors
J Christopher Muran, Bethany Teachman, Amelia Aldao, Jill Ehrenreich-May, Peter Fonagy, Leslie Greenberg, James Gross, Jeffrey Magnavita, Evan Mayo-Wilson, Shelley McMain, Jose Angel Soto, Lynn Bufka, Raquel Halfond, Howard Kurtzman, Jacob S Marzalik
Publication date
2024/1/12
Description
The Advisory Steering Committee for Development of Clinical Practice Guidelines created a working group to consider the feasibility of, and appropriate methods for, developing an APA clinical practice guideline for interventions that address a transdiagnostic change process, rather than a categorical disorder. Specifically, the working group was asked to determine whether development of a clinical practice guideline focused on emotion regulation was worth pursuing at this time, given the state of the scientific literature, feasibility, and considerations of clinical need and utility. The working group identified a set of goals for a clinical practice guideline based on the idea that if a guideline could mostly achieve these goals, it would be an advance for the field and worth the investment to try to develop a clinical practice guideline based on a transdiagnostic change process or principle. Goals: 1) Inform providers, patients and their families, payers and other stakeholders about what the empirical data indicate regarding the efficacy of treatments targeting emotion regulation2) Enhance clinical utility of a clinical practice guideline so we learn more than typical guidelines tell us about:● What works, for whom, and under what circumstances● What is known about widely-used treatments for which there is not rigorous evidence concerning efficacy● What is known about change processes or principles underlying the effects of efficacious treatmentsAfter careful consideration of the opportunities and challenges likely to arise in developing a clinical practice guideline on emotion regulation, the working group recommends developing and publishing three …
Scholar articles